Lord, Abbett & Co’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,197,182
Closed -$23.8M 574
2023
Q2
$23.8M Buy
1,197,182
+41,844
+4% +$845K 0.08% 313
2023
Q1
$19.8M Buy
1,155,338
+619,750
+116% +$12.1M 0.07% 350
2022
Q4
$10.5M Buy
535,588
+639
+0.1% +$11.8K 0.04% 420
2022
Q3
$8.54M Buy
534,949
+271,018
+103% +$4.23M 0.03% 421
2022
Q2
$3.63M Buy
263,931
+18,239
+7% +$217K 0.01% 519
2022
Q1
$3.9M Sell
245,692
-1,043,313
-81% -$18M 0.01% 571
2021
Q4
$28.1M Buy
1,289,005
+79,437
+7% +$2.17M 0.06% 349
2021
Q3
$36.2M Sell
1,209,568
-438,903
-27% -$16M 0.09% 329
2021
Q2
$73M Sell
1,648,471
-3,723
-0.2% -$162K 0.18% 173
2021
Q1
$73.3M Buy
1,652,194
+62,142
+4% +$3.41M 0.19% 177
2020
Q4
$87.2M Sell
1,590,052
-1,343
-0.1% -$49K 0.23% 131
2020
Q3
$36.4M Buy
1,591,395
+254,673
+19% +$6.28M 0.12% 271
2020
Q2
$28M Sell
1,336,722
-176,632
-12% -$3.18M 0.1% 320
2020
Q1
$21.1M Buy
1,513,354
+492,820
+48% +$9.76M 0.09% 314
2019
Q4
$23.2M Buy
1,020,534
+595,821
+140% +$9.95M 0.08% 368
2019
Q3
$4.95M Sell
424,713
-28,767
-6% -$357K 0.02% 634
2019
Q2
$6.8M Buy
453,480
+133,119
+42% +$2.32M 0.02% 625
2019
Q1
$5.62M Sell
320,361
-7,592
-2% -$120K 0.02% 642
2018
Q4
$4.86M Sell
327,953
-84,783
-21% -$1.41M 0.02% 655
2018
Q3
$10.2M Buy
412,736
+56,222
+16% +$1.22M 0.03% 618
2018
Q2
$7M Buy
+356,514
New +$6.74M 0.02% 680

Other funds holding RCKT